Sigma Healthcare Limited
SIG
Rank in Stocks
#1030
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Share Price
$1.98
Market Cap
$22.80B
Change (1 day)
-0.18%
Change (1 year)
2.40%
Country
AU
Trade Sigma Healthcare Limited (SIG)
Category
Healthcare
Earnings for Sigma Healthcare Limited (SIG)
Earnings in Jun 2026 TTM: $708.86M
According to Sigma Healthcare Limited latest financial reports the company's current earnings are $708.86M. In 2024 the company made an earning of $5.66M, an increase over its 2023 earnings that were of $3.85M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sigma Healthcare Limited from 2001 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $708.86M | 10,096.86% |
| 2025 | $6.95M | 22.78% |
| 2024 | $5.66M | 47.02% |
| 2023 | $3.85M | -165.59% |
| 2022 | $-5.87M | -126.98% |
| 2021 | $21.76M | -306.27% |
| 2020 | $-10.55M | -127.92% |
| 2019 | $37.78M | -40.47% |
| 2018 | $63.46M | 9.21% |
| 2017 | $58.11M | 6.92% |
| 2016 | $54.35M | -7.44% |
| 2015 | $58.71M | -1.86% |
| 2014 | $59.82M | 130.12% |
| 2013 | $26.00M | -65.98% |
| 2012 | $76.42M | -187.31% |
| 2011 | $-87.53M | -67.44% |
| 2010 | $-268.78M | -435.64% |
| 2009 | $80.08M | -18.27% |
| 2008 | $97.98M | -5.93% |
| 2007 | $104.16M | 37.29% |
| 2006 | $75.87M | 249.98% |
| 2004 | $21.68M | 59.62% |
| 2003 | $13.58M | 86.27% |
| 2002 | $7.29M | 86.95% |
| 2001 | $3.90M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $6.46B | 811.04% |
US
|
|
| - | - |
US
|
|
| $2.17B | 206.69% |
US
|
|
| - | - |
US
|
|
| $558.00M | -21.28% |
US
|
